India News | Genetek Lifesciences to Manufacture Amphotericin B Injection for Black Fungus Treatment
Get latest articles and stories on India at LatestLY. On the initiative of Union Minister Nitin Gadkari, Genetek Lifesciences of Wardha has received FDA approval to make Amphotericin B injection for black fungus infection during the COVID-19 period, a statement issued by the minister's office said.
Nagpur, May 14 (PTI) On the initiative of Union Minister Nitin Gadkari, Genetek Lifesciences of Wardha has received FDA approval to make Amphotericin B injection for black fungus infection during the COVID-19 period, a statement issued by the minister's office said.
Its production will begin in the next 15 days at its Wardha plant.
Right now the cost of an injection is Rs 7,000 and people are not getting it easily.
The injection made in Wardha will be available for just Rs 1,200, it added.
A total of 20,000 injections per day will be manufactured in the plant.
Genetek Lifesciences started production of Remdesivir injections, used in the treatment of COVID-19, in Wardha from Wednesday.
The company has received a loan licence to manufacture Remdesivir.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)